Can a quick iron boost before heart surgery lead to better long-term health?

NCT ID NCT06968936

Recruiting now Disease control Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving anemic patients a combination of iron, erythropoietin, and vitamin C for three days before heart surgery can improve their quality of life, sleep, and fatigue over the long term. Researchers will compare these patients to those receiving standard care. The goal is to see if this simple pre-surgery treatment helps patients feel better and recover more fully after their operation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Iron (sucrose iron), erythropoietin, and vitamin C
What this could lead to: If it works, this could point toward a simple, short-term treatment to improve recovery and quality of life after heart surgery for anemic patients.
What could go wrong: This is a sub-study of a larger trial, so results may be limited. The treatment is given only before surgery, and long-term benefits are uncertain. It may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anemia Iron Deficiencies iron deficiency anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEMIA CARDIAC SURGERY IRON DEFICIENCIES

Contacts and locations

Locations

Department of Anesthesiology, Second Affiliated Hospital, Zhejiang University School of Medicine
RECRUITING

Hangzhou, Zhejiang, 330100, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.